Feeley Kevin: insider trades.
Feeley Kevin reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($503K), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Feeley Kevin
Companies
| Company | Relationship | Transactions |
|---|---|---|
| GeneDx Holdings Corp. (WGS) | Officer · CHIEF FINANCIAL OFFICER | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | GeneDx Holdings Corp. | M | 7,197 | $0 | 48,673 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 586 | $94.26 | 48,087 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 1,079 | $99 | 44,945 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 541 | $96.9 | 47,494 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 1,470 | $98.27 | 46,024 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 52 | $95.41 | 48,035 | Form 4 |
| 2026-09-09 | GeneDx Holdings Corp. | M | 2,462 | $0 | 42,761 | Form 4 |
| 2026-09-09 | GeneDx Holdings Corp. | S | 1,285 | $84.22 | 41,476 | Form 4 |
| 2026-09-01 | GeneDx Holdings Corp. | S | 372 | $83.84 | 40,299 | Form 4 |
| 2026-09-01 | GeneDx Holdings Corp. | M | 717 | $0 | 40,671 | Form 4 |
Questions
What stock did Feeley Kevin buy or sell?
Feeley Kevin reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($503K), across 1 company.
Is Feeley Kevin the same person as other filers with this name?
This page covers SEC CIK 1944119 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/feeley-kevin-1944119.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.